Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania

AIDS Research and Human Retroviruses

Volumn 18, Issue 13, 2002, Pages 947-956

  Koulinska, Irene N ^a   Msamanga, Gernard ^a   Mwakagile, Davis ^a   Essex, Max ^a   Renjifo, Boris ^a  

^a Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TANZANIA; VERTICAL TRANSMISSION; VIRUS CLASSIFICATION; VIRUS RECOMBINATION; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TANZANIA;

EID: 0036384363     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760265614     Document Type: Article

References (53)

1. Kanki PJ, Hamel DJ, Sankale J-L, Hsieh Cc, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, Ndoye I, Essex M, and M'Boup S: HIV-1 subtypes differ in disease progression. J Infect Dis 1999;179:68-73.
2. Nelson JR, John GC, Carr JC, Lewis P, Kreiss JK, Jackson S, Nduati RW, Mbori-Ngacha D, Panteleeff DD, Bodrug S, Giachetti C, Bott MA, Richardson BA, Bwayo J, Ndinya-Achola J, and Overbaugh J: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403.
3. Peeters M, Vincent R, Perret J-L, Lasky M, Patrel D, Liegeois F, Courgnaud V, Seng R, Matton T, Molinier S, and Delaporte E: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:115-121.
4. Tscherning C, Alaeus A, Frederiksson R, Bjorndal A, Deng H, Littmen DR, Fenyö EM, and Albert J: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-188.
5. Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D, Garland M, Kagoma C, Kim A, Chaplin B, Hertzmark E, and Essex M: Differences in perinatal transmission between HIV-1 genotypes. J Hum Virol 2001;4:16-25.
6. McCutchan FE, Salminen M, Carr J, and Burke D: HIV-1 genetic diversity. AIDS 1996;10:S13-S20.
7. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin M, Saragosti S, Georges-Courbot M, Barré-Sinoussi F, and Brun-Vezinet F: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-1037.
8. Robertson DL, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, and Korber B: HIV-1 nomenclature proposal. A reference guide to HIV-1 classification. In: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Kuiken CFB, Hahn BH, Korber B, McCutchan F, Marx PA, Mellors JW, Mullins JL, Sodroski J, and Wolinsky S, eds.). Theoretical Biology and Biophysics Group, Los Alamos, New Mexico, 1999, pp. 492-505.
9. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn B, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, and Korber B: HIV-1 nomenclature proposal. Science 2000;288:55-56.
10. http://www.biols.susx.ac.uk/Biochem/Molbiol/maximum-chi-squared.html
11. Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW, Hegerich PA, St. Louis D, Burke DS, and McCutchan FE: Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996;70:5935-5943.
12. Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, and McCutchan FE: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G recombinants. Virology 1998;247:22-31.
13. Renjifo B, Chaplin B, Mwakagile D, Shah P, Vannberg F, Msamanga G, Hunter D, Fawzi W, and Essex M: Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. AIDS Res Hum Retroviruses 1998;14:635-638.
14. Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga G, Hunter D, Fawzi W, and Essex M: Emerging recombinant human immunodeficiency viruses: Uneven representation of the envelope V3 region. AIDS 1999;13:1613-1621.
15. Koulinska IN, Ndung'u T, Mwakagile D, Msamanga G, Kagoma C, Fawzi W, Essex M, and Renjifo B: A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res Hum Retroviruses 2001;17:423-431.
16. Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi W, and Essex M: Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology 1999;254:220-225.
17. Kliks S, Contag CH, Corliss H, Learn G, Rodrigo A, Wara D, Mullins JI, and Levy JA: Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns. AIDS Res Hum Retroviruses 2000;16:1223-1233.
18. Ahmad N, Baroudy BM, Baker RC, and Chappey C: Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995;69:1001-1012.
19. Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, and Essex M: Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. Virology 2000;274:402-411.
20. Fawzi W, Msamanga D, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Atelman G, Essex M, and Spiegelman D: A randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246-254.
21. Dittmar MT, Simmons G, Donaldson Y, Simmonds P, Clapham PR, Schulz TF, and Weiss RA: Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol 1997;71:5140-5147.
22. Carr JK, Foley BT, Leitner T, Salminen M, Korber B, and McCutchan F: Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retroviruses and AIDS 1998: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Korber B, Kuiken CL, Foley B, Hahn B, McCutchan F, Mellors JW, and Sodroski J, eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1998, pp. III-10-III-19.
23. Salminen MO, Carr JK, Burke DS, and McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995;11:1423-1425.
24. Siepel AC, Halpern AL, Macken C, and Korber BT: A computer program designed to screen rapidly for HIV subtype 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses 1995;11:1413-1416.
25. Maynard Smith J: Analyzing the mosaic structure of genes. J Mol Evol 1992;34:126-129.
26. Rose PP and Korber BT: Detecting hypermutations in viral sequences with an emphasis on G → A hypermutation. Bioinformatics 2000;16:400-401.
27. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD: Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1α region but lacking NF-κB binding sites. J Virol 1997;71:1651-1656.
28. Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carriere C, Courcoul M, Vigne R, Spire B, and Boulanger P: Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J Gen Virol 1998;79:1069-1081.
29. Jubier-Maurin V, Saragosti S, Perret JL, Mpoudi E, Esu-Williams E, Mulanga C, Liegeois F, Ekwalanga M, Delaporte E, and Peeters M: Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G, and H. AIDS Res Hum Retroviruses 1999;15:23-32.
30. Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhmema MJ, Marlink R, and Essex M: Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana. J Virol 1999;73:4427-4432.
31. Quinones-Mateu ME, Holguin A, Dopazo J, Najera I, and Domingo E: Point mutant frequencies in the pol gene of human immunodeficiency virus type 1 are two- to threefold lower than those of env. AIDS Res Hum Retroviruses 1996;12:1117-1128.
32. Hoelscher M, Kim B, Maboko L, Mhalu F, von Sonnenburg F, Birx DL, and McCutchan FE: The UNAIDS Network for HIV Isolation and Characterization: High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. AIDS 2001;15:1461-1470.
33. Costa LJ, Munerato P, Diaz RS, and Tanuri A: Generation of intersubtype human immunodeficiency virus type 1 recombinants in env gene in vitro: Influences in the biological behavior and in the establishment of productive infections. Virology 2000;268:440-451.
34. Cornelissen M, van Den Burg R, Zorgdrager F, and Goudsmit J: Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J Gen Virol 2000;81:515-523.
35. McCutchan FE, Carr JK, Bajani M, Sanders-Buell E, Harry TO, Stoeckli TC, Robbins KE, Gashau W, Nasidi A, Janssens W, and Kalish ML: Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 1999;254:226-234.
36. Montavon C, Toure-Kane C, Liegeois F, Mpoudi E, Bourgeois A, Vergne L, Perret JL, Boumah A, Saman E, Mboup S, Delaporte E, and Peeters M: Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000;23:363-374.
37. Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smolskaja T, Momot O, Mashkilleyson N, Chaplinskas S, Brummer-Korvenkontio H, Vanhatalo J, Leinikki P, and Salminen MO: HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-1919.
38. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J, Wagner R, Wolf H, Shao Y, Lai S, Beyrer C, and Yu XF: A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000;74:11286-11295.
39. Bachand F, Yao XJ, Hrimech M, Rougeau N, and Cohen EA: Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J Biol Chem 1999;274:9083-9091.
40. Sakai H, Shibata R, Sakuragi J, Sakuragi S, Kawamura M, and Adachi A: Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of viral particles. J Virol 1993;67:1663-1666.
41. - HIV-1 mutants in CEM cells suggests that Vif affects the late steps of the viral life cycle. Virology 1993;193:186-192.
42. gag precursor. J Virol 1997;71:9358-9365.
43. Malim MH, Hauber J, Le SY, Maizel JV, and Cullen BR: The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989;338:254-257.
44. Huffman KM, Arrigo SJ, and Schmidt MG: HIV-1 Rev promotes the nuclear export of unspliced and singly spliced RNAs in a mammalian cell-free export system. J Biomed Sci 1999;6:194-205.
45. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, and Berkhout B: Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000;74:3740-3751.
46. + T cells. J Virol 2001;75:7973-7986.
47. Vartanian JP, Meyerhans A, Åsjö B, and Wain-Hobson S: Selection, recombination and G → A hypermutation of human immunodeficiency virus type 1 genomes. J Virol 1991;65:1779-1788.
48. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, and Hahn BH: Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J Virol 1991;65:3973-3985.
49. European Collaborative Study: Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr Infect Dis J 1992;11:1018-1026.
50. Denny T, Yogev R, Gelman R, Skuza C, Oleska J, Chadwick E, Cheng SC, and Connor E: Lymphocyte subsets in healthy children during the first 5 years of life. JAMA 1992;267:1484-8148.
51. Holm-Hansen C, Ayehumie S, Johansson B, Nkya W, Shao J, and Haukenes G: HIV-1 proviral DNA sequences of env gp41 PCR amplificates from Tanzania. APMIS 1996;104:459-464.
52. Robbins KE, Bandea CI, Levin A, Goedert J, Blattner WA, Brubaker G, Brown TM, Schochetman G, Kalish ML, Shao J, and O'Brien TR: Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania. AIDS Res Hum Retroviruses 1996;12:1389-1391.
53. Siwka W, Schwinn A, Baczko K, Pardowitz I, Mhalu F, Shao J, Rethwilm A, and ter Meulen V: vpu and env sequence variability of HIV-1 isolates from Tanzania. AIDS Res Hum Retroviruses 1994;12:1753-1754.